Literature DB >> 9382106

A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome.

J J Assink1, N T Tijmes, J B ten Brink, R J Oostra, F C Riemslag, P T de Jong, A A Bergen.   

Abstract

The aim of this study was to identify the chromosomal location of the disease-causing gene in a family apparently segregating X-linked optic atrophy. A large family of 45 individuals with a four-generation history of X-linked optic atrophy was reexamined in a full ophthalmic as well as electrophysiological examination. A DNA linkage analysis of the family was undertaken in order to identify the chromosomal location of the disease-causing gene. Linkage analysis was performed with 26 markers that spanned the entire X chromosome. The affected males showed very early onset and slow progression of the disease. Ophthalmic study of the female carriers did not reveal any abnormalities. Close linkage without recombination was found at the MAOB locus (maximum LOD score [Zmax] 4.19). The Zmax - 1 support interval was found at a recombination fraction of .076 distal and .018 proximal to MAOB. Multipoint linkage analysis placed the optic atrophy-causing gene in the Xp11.4-p11.21 interval between markers DXS993 and DXS991, whereas any other localization along the X chromosome could be excluded.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9382106      PMCID: PMC1715990          DOI: 10.1086/514884

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  A family with apparently sex-linked optic atrophy.

Authors:  L N Went; E C De Vries-De Mol; H J Völker-Dieben
Journal:  J Med Genet       Date:  1975-03       Impact factor: 6.318

Review 2.  LEBER'S DISEASE IN THE NETHERLANDS.

Authors:  A H VANSENUS
Journal:  Doc Ophthalmol       Date:  1963       Impact factor: 2.379

3.  No evidence for 'skewed' inactivation of the X-chromosome as cause of Leber's hereditary optic neuropathy in female carriers.

Authors:  R J Oostra; S Kemp; P A Bolhuis; E M Bleeker-Wagemakers
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

4.  Four families with the dominant infantile form of optic nerve atrophy.

Authors:  C C Kok-van Alphen
Journal:  Acta Ophthalmol (Copenh)       Date:  1970

5.  Reevaluation of the linkage of an optic atrophy susceptibility gene to X-chromosomal markers in Finnish families with Leber hereditary optic neuroretinopathy (LHON)

Authors:  V Juvonen; J Vilkki; P Aula; E Nikoskelainen; M L Savontaus
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

6.  Dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy. A new syndrome.

Authors:  R L Treft; G E Sanborn; J Carey; M Swartz; D Crisp; D C Wester; D Creel
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

7.  GAPO syndrome: report of three affected brothers.

Authors:  A R Gagliardi; C H González; R Pratesi
Journal:  Am J Med Genet       Date:  1984-10

8.  Familial opticoacoustic nerve degeneration and polyneuropathy.

Authors:  R N Rosenberg; A Chutorian
Journal:  Neurology       Date:  1967-09       Impact factor: 9.910

9.  Dominant optic nerve atrophy with progressive hearing loss and chronic progressive external ophthalmoplegia (CPEO).

Authors:  F Meire; J J De Laey; S de Bie; M van Staey; M T Matton
Journal:  Ophthalmic Paediatr Genet       Date:  1985-02

10.  Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis.

Authors:  H Eiberg; B Kjer; P Kjer; T Rosenberg
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

View more
  13 in total

Review 1.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

2.  [Hereditary optic atrophies].

Authors:  C M Poloschek; W A Lagrèze
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

Review 3.  Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.

Authors:  M Votruba; A T Moore; S S Bhattacharya
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

4.  Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.

Authors:  M Votruba; D Thiselton; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 5.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 6.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

7.  The ERCC6 gene and age-related macular degeneration.

Authors:  Dominique C Baas; Dominiek D Despriet; Theo G M F Gorgels; Julie Bergeron-Sawitzke; André G Uitterlinden; Albert Hofman; Cornelia M van Duijn; Joanna E Merriam; R Theodore Smith; Gaetano R Barile; Jacoline B ten Brink; Johannes R Vingerling; Caroline C W Klaver; Rando Allikmets; Michael Dean; Arthur A B Bergen
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

Review 8.  A review of primary hereditary optic neuropathies.

Authors:  M Votruba; S Aijaz; A T Moore
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia.

Authors:  Juliette J Kahle; Natali Gulbahce; Chad A Shaw; Janghoo Lim; David E Hill; Albert-László Barabási; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2010-11-15       Impact factor: 6.150

Review 10.  The optic nerve: a "mito-window" on mitochondrial neurodegeneration.

Authors:  Alessandra Maresca; Chiara la Morgia; Leonardo Caporali; Maria Lucia Valentino; Valerio Carelli
Journal:  Mol Cell Neurosci       Date:  2012-08-15       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.